AVTOIMUNSKI VIDIKI PREZGODNJE MENOPAVZE

I-156 Zdrav Vestn 2009; 78: SUPPL I
žnost avtoimunske patogeneze. Kombinacija različnih
kazalcev, ki opredeljujejo sistemsko in organsko-specifično
avtoimunost, potrjuje prisotnost avtoagresivnih
procesov pri nekaterih bolnicah. Hkrati pa se kaže tudi
potreba, da bi našli zanesljiv in preprost diagnostični
postopek, da bi ugotovili resnično prevalenco avtoimunske
etiologije ovarijske bolezni.
Literatura
1. Conway GS. Premature ovarian failure. Br Med Bull 1999; 56:
643–9.
2. Anasti IN. Premature ovarian failure: an update. Fertil Steril 1998;
70: 1–15.
3. Taylor AE. Systemic adversities of ovarian failure. J Soc Gynecol
Investig 2001; 8: S7–S9.
4. Snowdown DA, Kane RL, Beeson WL, Burke GL, Sprafka SM,
Potter J, et al. Is early natural menopause a biologic marker of
health and aging? Am J Public Health 1989; 79: 709–14.
5. Conway GS, Kaltsas G, Patel A, Davies MS, Jocobs HS. Characterisation
of idiopathic premature ovarian failure. Fertil Steril 1996;
65: 337–41.
6. Morita Y, Tilly IL. Oocytic oophoritis: like sand through an hourglass.
Dev Biol 1999; 213: 1–17.
7. Zuckerman S. The number of oocytes in the mature ovary. Recent
Prog Horm Res 1951; 6: 63–108.
8. Johnson J, Canning J, Kaneko T, Pru SK, Tilly JL. Germline stem
cells and follicular renewal in the postnatal mammalian ovary.
Nature 2004; 428: 145–50.
9. Byskof AG, Faddy MJ, Lemmen JG, Andersen CY. Eggs forever?
Differentiation 2005; 73: 438–46.
10. Liu Y, Wu C, Lyu Q, Yang D, Albertini DF, Keefe DL, et al. Germline
stem cellls and neo-oogenesis in the adult human ovary.
Dev Biol 2007; 306: 112–20.
11. Bukovsky A, Virant-Klun I, Svetlikova M, Willson I. Ovarian germ
cells. Methods Enyzmol 2006; 419: 208–58.
12. Bukovsky A, Virant-Klun I. Adult stem cells in the human ovary.
In: Carlos S, Pellicer A, eds. Stem cells in reproductive medicine:
Basic science and therapeutic potential. London: Informa Healthcare;
2006. p. 53–69.
13. Duff GL, Bernstein C. Five cases of Addisons disease with socalled
atrophy of the adrenal cortex. Bull Johns Hopkins Hospital
1933; 52: 637–40.
14. Bakalov VK, Vanderhoof VH, Body CA, Nelson LM. Adrenal
autoantibodies detected asymptomatic auto-immune adrenal
insufficiency in young women with spontaneus premature
ovarian failure. Hum Reprod 2002; 17: 2096–100.
15. Betterle C, Volpato M. Adrenal and ovarian autoimmunity. Eur
J Endocrinol 1998; 138: 16–25.
16. Dalpra C, Chen S, Furmaniak J. Autoantibodies to steroidogenic
enyzmes in patients with premature ovarian failure and Addison's
disease. Eur J Endocrinol 2003; 148: 565–70.
17. De Moraes-Ruehsen M, Blizzard RM, Garcia-Bunner R, Jones GS.
Autoimmunity and ovarian failure. Am J Obstet Gynecol 1972;
112: 693–703.
18. Betterle C, Ross A, Dalla Pria S, Artifoni A. Premature ovarian
failure: autoimmunity and natural history. Clin Endocrinol 1993;
39: 35–43.
19. Alper MM, Garner PR. Premature ovarian failure: its relationship
to autoimmune disease. Obstet Gynecol 1985; 66: 27–30.
20. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity
and antigenic targets in ovarian pathology. Hum Reprod
Update 2004; 10: 163–75.
21. Irvine WJ. Premature menopause in autoimmune disease. Lancet
1969; 1: 565–70.
22. Valloton MB, Forbes AP. Antibodies to cytoplasm of ovary. Lancet
1966; 2: 264–5.
23. Ho PC, Tang GWK, Fu KH, Fan MC, Lawton WM. Immunologic
studies in patients with premature ovarian failure. Obstet Gynecol
1988; 71: 622–6.
24. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating
antiovarian antibodies in premature ovarian failure. Obstet
Gynecol 1986; 68: 850–4.
25. Coulam CB, Ryan RJ. Premature menopause. Etiology. Am J
Obstet Gynecol 1979; 133: 639–43.
26. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed
towards ovaries among women with premature ovarian
failure. Am J Reprod Immunol Microbiol 1985; 9: 23–4.
27. Luborsky J, Llanes B, Davies S, Binor Z, Radwanska E, Pong R.
Ovarian autoimmunity: greater frequency of autoantibodies in
premature menopause and unexplained infertility than in the
general population. Clin Immunol 1999; 90: 368–74.
28. Meyer W, Lavy G, De Cherney A, Visintin I. Evidence of gonadal
and gonadotropin antibodies in woman with suboptimal ovarian
response to exogenous gonadotropin. Obstet Gynecdol 1990;
75: 795–9.
29. Luborsky J, Pong R. Pregnancy outcome and ovarian autoimmunity
in infertility patients undergoing controlled ovarian
hyperstimulation. Am J Reprod Immunol 2000; 44: 261–5.
30. Luborsky J, Thiruppathi P, Rivany B. Evidence for different etiologies
of low estradiol response to FSH: age-related accelerated
luteinization of follicles of presence of ovarian autoantibodies.
Hum Reprod 2002; 17: 2641–9.
31. Luborsky J. Ovarian autoimmune disease and aovarian autoantibodies:
a review. J Womens Health Gender Based Med 2002;
11:585–99.
32. Mignot MH, Drexhage HA, Kleingeld M. Premature ovarian failure
II. Considerations of cellular immunity defects. Eur J Obstet
Gynecol Reprod Biol 1989; 30: 67–72.
33. Miyake T, Sato Y, Takeuchi S. Implications of circulating autoantibodies
and peripheral blood lymphocyte subset for the
genesis of premature ovarian failure. J Reprod Immunol 1987;
12: 163–71.
34. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic
self-tolerance maintained by activated T cells expressing IL-2
receptor alpha-chains (CD25). Breakdown of a single mechanism
of self-tolerance causes various autoimmune diseases. J Immunol
1995; 155: 1151–64.
35. Chernysmov VP, Radysh TV, Gura IV, Tatarshuk TP, Khominskaya
ZB. Immune disorders in women with premature ovarian failure.
Am J Reprod Immunol. 2001; 46: 220–5.
36. Ho PC, Tang GW, Lawton JW. Lymphocyte subsets and serum
immunoglobulins in patients with premature ovarian failure
before and after estrogen replacement. Hum Reprod 1993; 8:
714–6.
37. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure
and ovarian autoimmunity. Endocrine Rev 1997; 11: 107–34.
38. Fanchin R, Schonauer LM, Righini C. Serum anti-Mullerian hormone
is more strongly related to ovarian follicular status than
serum inhibin B, estradiol, FSH, LH on day 3. Hum Reprod 2003;
18: 323–7.
39. Van Rooij IA, Tonkelaar I, Broekmans FJ. Anti-Mullerian hormone
is a promising predictor for the occurence of the menopausal
transition. Menopause 2004; 11: 601–6.
40. Van Rooij IA, Broekmans FJ, Scheffer GJ. Serum anti mullerian
hormone levels best reflect the reproductive decline with age in
normal women with proven fertility: a longitudinal study. Fertil
Steril 2005; 83: 979–87.
Prispelo 2009-09-03, sprejeto 2009-10-01